Hypomethylating agents for adult patients with acute myeloid leukaemia
Authors:
- 7 December 2011
- reference entry
- Published by Wiley
- No. 12
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid LeukemiaJournal of Clinical Oncology, 2010
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetBlood, 2010
- Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative GroupJournal of Clinical Oncology, 2009
- Phase I Study of Decitabine Alone or in Combination With Valproic Acid in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2007
- Age and acute myeloid leukemiaBlood, 2006
- Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2003
- Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma lineCell Biochemistry and Biophysics, 1989
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976